• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of omalizumab on pollen-induced seasonal allergic rhinitis: An observational study in clinical practice.

作者信息

Hirano Kojiro, Suzaki Isao, Uruma Shuhei, Tokudome Takatoshi, Matuura Shohei, Yano Mai, Kobayashi Sei, Tanaka Akihiko, Hirano Yuni, Watanabe Hideaki, Kobayashi Hitome

机构信息

Department of Otorhinolaryngology, Showa University School of Medicine, Tokyo, Japan.

Department of Otorhinolaryngology, Fujigaoka hospital, Yokohama, Kanagawa, Japan.

出版信息

Int Forum Allergy Rhinol. 2021 Nov;11(11):1588-1591. doi: 10.1002/alr.22827. Epub 2021 May 28.

DOI:10.1002/alr.22827
PMID:34047460
Abstract
摘要

相似文献

1
Impact of omalizumab on pollen-induced seasonal allergic rhinitis: An observational study in clinical practice.奥马珠单抗对花粉诱导的季节性变应性鼻炎的影响：一项临床实践中的观察性研究。
Int Forum Allergy Rhinol. 2021 Nov;11(11):1588-1591. doi: 10.1002/alr.22827. Epub 2021 May 28.
2
Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.奥马珠单抗对季节性变应性鼻炎症状的影响：一项随机对照试验。
JAMA. 2001 Dec 19;286(23):2956-67. doi: 10.1001/jama.286.23.2956.
3
Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis.单克隆抗体在过敏性介导疾病中的应用经验：季节性变应性鼻炎
J Allergy Clin Immunol. 2001 Aug;108(2 Suppl):S84-8. doi: 10.1067/mai.2001.116433.
4
Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.间隔一年使用奥马珠单抗重新治疗日本雪松花粉引起的季节性过敏性鼻炎有效且耐受性良好。
Int Arch Allergy Immunol. 2009;149(3):239-45. doi: 10.1159/000199719. Epub 2009 Feb 12.
5
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.抗IgE联合特异性免疫疗法治疗多敏性儿童和青少年季节性过敏性鼻炎的疗效
J Allergy Clin Immunol. 2002 Feb;109(2):274-80. doi: 10.1067/mai.2002.121949.
6
Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.奥马珠单抗治疗日本雪松花粉引起的季节性过敏性鼻炎有效且安全。
Allergol Int. 2006 Dec;55(4):379-86. doi: 10.2332/allergolint.55.379.
7
Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.在季节性变应性鼻炎患者的第二个豚草花粉季节中，使用重组人源化抗IgE单克隆抗体奥马珠单抗进行再治疗的耐受性。
Allergy Asthma Proc. 2003 Sep-Oct;24(5):323-9.
8
[Pollen indicators].
Rev Mal Respir. 2009 Jun;26(6):685-6. doi: 10.1016/s0761-8425(09)74700-x.
9
Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.奥马珠单抗（Xolair）用于治疗季节性变应性鼻炎患儿：白三烯释放作为监测治疗效果的潜在体外参数
Pediatr Allergy Immunol. 2007 Sep;18(6):523-7. doi: 10.1111/j.1399-3038.2007.00557.x.
10
[TREATMENT STRATEGY USING BIOLOGICS FOR POLLINOSIS].
Arerugi. 2021;70(8):918-923. doi: 10.15036/arerugi.70.918.

引用本文的文献

1
Evaluating the Efficacy of Omalizumab in Severe Cedar Seasonal Allergic Rhinitis in Japan.评估奥马珠单抗在日本重度雪松季节性过敏性鼻炎中的疗效。
Cureus. 2024 Jul 2;16(7):e63714. doi: 10.7759/cureus.63714. eCollection 2024 Jul.
2
Successful Omalizumab Treatment of Rhinogenic Contact Point Headache Complicated by Severe Cedar Pollinosis: A Case Report.奥马珠单抗成功治疗并发严重雪松花粉症的鼻源性接触点头痛：一例报告
Cureus. 2023 Dec 24;15(12):e51046. doi: 10.7759/cureus.51046. eCollection 2023 Dec.
3
Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study.
预防奥马珠单抗治疗季节性变应性鼻结膜炎：一项回顾性队列研究。
Front Immunol. 2022 Jul 28;13:913424. doi: 10.3389/fimmu.2022.913424. eCollection 2022.
4
Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology.变应性鼻炎的药物治疗：马来西亚过敏与免疫学会的共识声明
J Asthma Allergy. 2022 Aug 2;15:983-1003. doi: 10.2147/JAA.S374346. eCollection 2022.